-
1
-
-
41349099104
-
Cancer statistics, 2008
-
Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2008. CA Cancer J Clin 58 (2008) 71
-
(2008)
CA Cancer J Clin
, vol.58
, pp. 71
-
-
Jemal, A.1
Siegel, R.2
Ward, E.3
-
2
-
-
0036138580
-
Interferon-alfa as a comparative treatment for clinical trials of new therapies against advanced renal cell carcinoma
-
Motzer R.J., Bacik J., Murphy B.A., et al. Interferon-alfa as a comparative treatment for clinical trials of new therapies against advanced renal cell carcinoma. J Clin Oncol 20 (2002) 289
-
(2002)
J Clin Oncol
, vol.20
, pp. 289
-
-
Motzer, R.J.1
Bacik, J.2
Murphy, B.A.3
-
3
-
-
0036895290
-
Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma
-
Zisman A., Pantuck A.J., Wieder J., et al. Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma. J Clin Oncol 20 (2002) 4559
-
(2002)
J Clin Oncol
, vol.20
, pp. 4559
-
-
Zisman, A.1
Pantuck, A.J.2
Wieder, J.3
-
4
-
-
20244386849
-
Using tumor markers to predict the survival of patients with metastatic renal cell carcinoma
-
Kim H.L., Seligson D., Liu X., et al. Using tumor markers to predict the survival of patients with metastatic renal cell carcinoma. J Urol 173 (2005) 1496
-
(2005)
J Urol
, vol.173
, pp. 1496
-
-
Kim, H.L.1
Seligson, D.2
Liu, X.3
-
5
-
-
34447577927
-
STAT3 polymorphism predicts interferon-alfa response in patients with metastatic renal cell carcinoma
-
Ito N., Eto M., Nakamura E., et al. STAT3 polymorphism predicts interferon-alfa response in patients with metastatic renal cell carcinoma. J Clin Oncol 25 (2007) 2785
-
(2007)
J Clin Oncol
, vol.25
, pp. 2785
-
-
Ito, N.1
Eto, M.2
Nakamura, E.3
-
6
-
-
35448992847
-
Silent polymorphisms speak: how they affect pharmacogenomics and the treatment of cancer
-
Sauna Z.E., Kimchi-Sarfaty C., Ambudkar S.V., et al. Silent polymorphisms speak: how they affect pharmacogenomics and the treatment of cancer. Cancer Res 67 (2007) 9609
-
(2007)
Cancer Res
, vol.67
, pp. 9609
-
-
Sauna, Z.E.1
Kimchi-Sarfaty, C.2
Ambudkar, S.V.3
-
7
-
-
35348870611
-
The AA genotype of the regulatory BCL2 promoter polymorphism (938C>A) is associated with a favorable outcome in lymph node negative invasive breast cancer patients
-
Bachmann H.S., Otterbach F., Callies R., et al. The AA genotype of the regulatory BCL2 promoter polymorphism (938C>A) is associated with a favorable outcome in lymph node negative invasive breast cancer patients. Clin Cancer Res 13 (2007) 5790
-
(2007)
Clin Cancer Res
, vol.13
, pp. 5790
-
-
Bachmann, H.S.1
Otterbach, F.2
Callies, R.3
-
8
-
-
35948970991
-
Association of matrix metalloproteinase-8 gene variation with breast cancer prognosis
-
Decock J., Long J.R., Laxton R.C., et al. Association of matrix metalloproteinase-8 gene variation with breast cancer prognosis. Cancer Res 67 (2007) 10214
-
(2007)
Cancer Res
, vol.67
, pp. 10214
-
-
Decock, J.1
Long, J.R.2
Laxton, R.C.3
-
9
-
-
36349003600
-
Impact of interleukin-10 polymorphisms (-1082 and -3575) on the survival of patients with lymphoid neoplasms
-
Domingo-Domenech E., Benavente Y., Gonzalez-Barca E., et al. Impact of interleukin-10 polymorphisms (-1082 and -3575) on the survival of patients with lymphoid neoplasms. Haematologica 92 (2007) 1475
-
(2007)
Haematologica
, vol.92
, pp. 1475
-
-
Domingo-Domenech, E.1
Benavente, Y.2
Gonzalez-Barca, E.3
-
10
-
-
35949002836
-
MCP-1 promoter polymorphism at 2518 is associated with metastasis of nasopharyngeal carcinoma after treatment
-
Tse K.P., Tsang N.M., Chen K.D., et al. MCP-1 promoter polymorphism at 2518 is associated with metastasis of nasopharyngeal carcinoma after treatment. Clin Cancer Res 13 (2007) 6320
-
(2007)
Clin Cancer Res
, vol.13
, pp. 6320
-
-
Tse, K.P.1
Tsang, N.M.2
Chen, K.D.3
-
11
-
-
59949102663
-
Cytogenetic profile predicts prognosis of patients with clear cell renal cell carcinoma
-
Klatte T., Rao P.N., de Martino M., et al. Cytogenetic profile predicts prognosis of patients with clear cell renal cell carcinoma. J Clin Oncol 27 (2009) 746
-
(2009)
J Clin Oncol
, vol.27
, pp. 746
-
-
Klatte, T.1
Rao, P.N.2
de Martino, M.3
-
12
-
-
0035107383
-
Expression of hypoxia-inducible cell-surface transmembrane carbonic anhydrases in human cancer
-
Ivanov S., Liao S.Y., Ivanova A., et al. Expression of hypoxia-inducible cell-surface transmembrane carbonic anhydrases in human cancer. Am J Pathol 158 (2001) 905
-
(2001)
Am J Pathol
, vol.158
, pp. 905
-
-
Ivanov, S.1
Liao, S.Y.2
Ivanova, A.3
-
13
-
-
0037314709
-
Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy
-
Bui M.H., Seligson D., Han K.R., et al. Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy. Clin Cancer Res 9 (2003) 802
-
(2003)
Clin Cancer Res
, vol.9
, pp. 802
-
-
Bui, M.H.1
Seligson, D.2
Han, K.R.3
-
14
-
-
21044442672
-
Carbonic anhydrase IX expression predicts outcome of interleukin 2 therapy for renal cancer
-
Atkins M., Regan M., McDermott D., et al. Carbonic anhydrase IX expression predicts outcome of interleukin 2 therapy for renal cancer. Clin Cancer Res 11 (2005) 3714
-
(2005)
Clin Cancer Res
, vol.11
, pp. 3714
-
-
Atkins, M.1
Regan, M.2
McDermott, D.3
-
15
-
-
33746843631
-
Racial disparity in outcomes of a clinical trial population with metastatic renal cell carcinoma
-
Tripathi R.T., Heilbrun L.K., Jain V., et al. Racial disparity in outcomes of a clinical trial population with metastatic renal cell carcinoma. Urology 68 (2006) 296
-
(2006)
Urology
, vol.68
, pp. 296
-
-
Tripathi, R.T.1
Heilbrun, L.K.2
Jain, V.3
-
16
-
-
33846504706
-
A "silent" polymorphism in the MDR1 gene changes substrate specificity
-
Kimchi-Sarfaty C., Oh J.M., Kim I.W., et al. A "silent" polymorphism in the MDR1 gene changes substrate specificity. Science 315 (2007) 525
-
(2007)
Science
, vol.315
, pp. 525
-
-
Kimchi-Sarfaty, C.1
Oh, J.M.2
Kim, I.W.3
-
17
-
-
0037345672
-
Expanding the association between the APOE gene and the risk of Alzheimer's disease: possible roles for APOE promoter polymorphisms and alterations in APOE transcription
-
Laws S.M., Hone E., Gandy S., et al. Expanding the association between the APOE gene and the risk of Alzheimer's disease: possible roles for APOE promoter polymorphisms and alterations in APOE transcription. J Neurochem 84 (2003) 1215
-
(2003)
J Neurochem
, vol.84
, pp. 1215
-
-
Laws, S.M.1
Hone, E.2
Gandy, S.3
-
18
-
-
19544391975
-
A synonymous SNP of the corneodesmosin gene leads to increased mRNA stability and demonstrates association with psoriasis across diverse ethnic groups
-
Capon F., Allen M.H., Ameen M., et al. A synonymous SNP of the corneodesmosin gene leads to increased mRNA stability and demonstrates association with psoriasis across diverse ethnic groups. Hum Mol Genet 13 (2004) 2361
-
(2004)
Hum Mol Genet
, vol.13
, pp. 2361
-
-
Capon, F.1
Allen, M.H.2
Ameen, M.3
-
19
-
-
55049093740
-
Molecular biology of renal cortical tumors
-
Klatte T., and Pantuck A.J. Molecular biology of renal cortical tumors. Urol Clin North Am 35 (2008) 573
-
(2008)
Urol Clin North Am
, vol.35
, pp. 573
-
-
Klatte, T.1
Pantuck, A.J.2
-
20
-
-
55049123815
-
Systemic therapy for metastatic renal cell carcinoma
-
Kroog G.S., and Motzer R.J. Systemic therapy for metastatic renal cell carcinoma. Urol Clin North Am 35 (2008) 687
-
(2008)
Urol Clin North Am
, vol.35
, pp. 687
-
-
Kroog, G.S.1
Motzer, R.J.2
|